Last week, The Flowr Corporation (TSXV:FLWR) announced their partnership with Ace Hill, a millennial-focused beer and alcoholic drinks company, to market a line of pre-rolled cannabis products in Ontario and British Columbia. According to the Globe and Mail, this licensing agreement could be the spark of a new trend in the cannabis sector. Alcohol companies, such as Constellation Brands Inc. and Molson Coors Brewing Company, are looking to capitalize on the new and rapidly expanding cannabis market. However, conversations are also happening between smaller licensed producers looking to create a brand for themselves and craft brewers that would like a new revenue stream.

Licensed producers wishing to create a brand name for themselves have to navigate a highly restrictive marketing environment. Packaging needs to be plain and there are limited advertising opportunities. On top of this, marketing cannabis as a lifestyle brand is prohibited, which makes partnering with existing brands an appealing option, but partnering with alcohol companies is not simple. Under the regulations, if a company starts to brand their cannabis product line under their alcohol brand, then all of their products will be considered cannabis related and will be subjected to cannabis marketing restrictions.

To get around these restrictions, Ace Hill had to create a separate corporate entity, with a different name, logos and brand elements. By switching things around a little bit ensures that the products being sold are compliant with cannabis regulations, but are still recognizable to consumers of the alcohol brand. Flowr’s partnership with Ace Valley gives them a recognizable brand to sell their products under and it allows them to work with a team that has seen significant growth in the two years since they opened their doors.

To read the full article, click here.

Click here to connect with The Flowr Corporation (TSXV:FLWR) for an Investor Presentation.


Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less